Michael Welsh, MD, a name synonymous with cystic fibrosis research breakthroughs, recounted a pivotal moment from 1990. Seeking dedicated lab time, Dr. Welsh approached Dr. Frank Abboud, then Chair of Internal Medicine, requesting a sabbatical. Dr. Abboud’s immediate agreement and subsequent question, “Where are you gonna go?” were met with Dr. Welsh’s defining answer: “Nowhere, I’m going into my lab.” This anecdote encapsulates Dr. Welsh’s unwavering dedication and the supportive environment that fostered his groundbreaking work.
This story was shared at the 2018 Warren Alpert Foundation Prize Symposium at Harvard Medical School, where Dr. Welsh was honored as a recipient. It resonated again last week in Iowa City, amongst colleagues and trainees. Dr. Welsh emphasized that the supportive atmosphere at Iowa, where he conducted his seminal research on the CFTR gene and its link to chloride transport, was crucial to his success. This discovery revolutionized cystic fibrosis understanding and treatment. He acknowledged numerous individuals, highlighting their essential contributions to his work, stating, “The Alpert Prize is as much theirs.” His message was clear: his achievements were deeply rooted in the collaborative spirit and dedication of his Iowa team.
Following a reception hosted by the Division of Pulmonary, Critical Care, and Occupational Medicine, and remarks from current Department Chair Dr. Dale Abel, the evening celebrated not just past achievements but ongoing impact. Dr. Abel lauded Dr. Welsh’s enduring vision and leadership, noting his “grandfather” status in mentoring generations of researchers who continue to propel cystic fibrosis research at the University of Iowa. The event served as a heartfelt tribute to Dr. Welsh and a recognition of the collective effort behind scientific advancement. Attendees, including colleagues, family, and friends, celebrated Dr. Welsh’s prestigious award and his gracious acknowledgment of shared success.
Michael Welsh at the Warren Alpert Foundation Prize Symposium
The Pivotal Sabbatical: “Welsh Where” Innovation Began
Dr. Welsh’s anecdote about his impromptu sabbatical request highlights a key aspect of his journey: the environment where his innovation flourished. When asked “Welsh Where” he planned to spend his sabbatical, his answer, “Nowhere, I’m going into my lab,” speaks volumes. It wasn’t about geographical relocation, but rather a focused immersion within his existing research space at the University of Iowa. This pivotal moment, facilitated by the support of Dr. Abboud and colleagues who covered his clinical duties, allowed Dr. Welsh to delve deeply into the CFTR gene. This dedicated time was instrumental in the discovery that changed the trajectory of cystic fibrosis research.
Dr. Welsh speaking at the symposium
Iowa: Where Collaboration Fueled Discovery
The narrative emphasizes that “welsh where” groundbreaking discoveries happen is often within supportive and collaborative ecosystems. Dr. Welsh repeatedly stressed that his achievements were not solitary efforts. He explicitly named and thanked numerous colleagues, both past and present, underscoring the collective nature of scientific progress. This collaborative spirit at the University of Iowa, where individuals readily supported each other, enabled Dr. Welsh to pursue his research unburdened by other responsibilities. This environment, “welsh where” ideas were nurtured and teamwork was valued, proved fertile ground for the CFTR breakthrough.
Attendees listening to Dr. Welsh's speech
Dr. Dale Abel praising Dr. Welsh
From Iowa to Global Impact: “Welsh Where” Legacy Extends
While “welsh where” Dr. Welsh’s crucial discoveries originated is firmly rooted in Iowa, his impact is undeniably global. The Warren Alpert Foundation Prize, a prestigious international award, recognizes his contributions to medical science. Furthermore, Dr. Abel’s remarks highlight the enduring legacy of Dr. Welsh’s mentorship. His influence now extends through generations of researchers, ensuring that the University of Iowa remains a vital center for cystic fibrosis research. “Welsh where” his initial work transformed the field continues to be a place where future breakthroughs are cultivated, solidifying his lasting contribution to global health.
Colleagues congratulating Dr. Welsh
Dr. Welsh interacting with attendees
Group photo at the event 
Another group photo with Dr. Welsh
Dr. Welsh and attendees in conversation
Attendees at the reception 
Close-up of attendees conversing
Attendees raising glasses in celebration
Candid shot of attendees 
Smiling attendees at the event
Dr. Welsh with a group of attendees
Conclusion: Celebrating Collaborative Science and Enduring Impact
Dr. Michael Welsh’s recognition with the Warren Alpert Foundation Prize is a testament to his groundbreaking contributions to cystic fibrosis research. However, his story is equally a powerful reminder that scientific breakthroughs are rarely solitary endeavors. “Welsh where” discovery unfolded was within a supportive and collaborative environment at the University of Iowa. His emphasis on the crucial roles of his colleagues and mentors underscores the importance of teamwork in scientific advancement. Dr. Welsh’s legacy extends beyond his own discoveries, inspiring future generations of researchers and reinforcing the value of collaborative science in addressing complex medical challenges. His journey highlights that “welsh where” innovation truly flourishes is within communities that champion shared effort and mutual support.
